publications only reflects part of his scientific productivity. Another important benchmark reflecting the impact and value of published work is measured by how many times colleagues cite one's articles in their own publications. Using this parameter, Seng-jaw's 300 scientific publications were quoted in the literature more than 1,000 times during each one of the past four years, or a total of 18,600 times over 30 years, an average of 63 citations for each of his articles.
His impact in the melanoma and virology fields is also evident in his ten most cited articles (see Table 1 ). Two of these with Dr. Richard Whitley were cited 622 and 385 times, respectively. Six of the remaining eight were melanoma papers cited 300 to 500 times each. His top two cited papers, published in 2001, reflected the revolutionary changes he brought to the staging and prognosis of melanoma. These two papers have been cited 1,075 and 1,436 times, respectively. Also, for 30 years, Dr. Soong played an instrumental role in melanoma education through his coediting the seminal textbook Cutaneous Melanoma, currently in its 5th edition.
In addition to celebrating the remarkable professional achievements of Seng-jaw Soong, his colleagues admired him for his authentic character, his genuine, sensitive, and humble personality, his commitment as a mentor and teacher, and his devotion as a husband and father.
Some memorable comments that reflect how others defined his legacy:
From Dr. David Byrd at the University of Washington, Vice-Chair of the AJCC:
I also had the pleasure to work with him for many years through AJCC activities and others. I agree completely with your comments about his authenticity and humbleness. I would add that he also embodied the highest integrity, remarkably high standard setting for fidelity in interpretation of data, and a commitment to full collegiality with his partners in cancer.
From Dr. Stephen Edge at Roswell Park CC in Buffalo, the past-Chair of the AJCC:
Seng-jaw made such enormous contributions over the years to the cause of improving patient care and outcomes. His work in understanding melanoma in particular has benefited untold numbers of people around the world. His influence and impact will continue in our field for decades to come. Seng-jaw was an incredibly talented, team-oriented, and genuinely gentle human being in every dimension. His interest and mastery of the clinical problem of melanoma over the past few decades-with paradigm-shifting achievement in staging and prognosis-has helped us all as we strive to conquer this challenging problem and better serve our patients worldwide. His legacy as a statistician who became entrenched in the clinical aspects of the disease process has served and will continue to serve as a model for all statisticians and bioinformaticians alike. We will all miss him dearly.
From Dr. John Thompson, Director of the Melanoma Institute of Australia in Sydney:
Seng-jaw leaves a remarkable legacy and will long be remembered as a humble but hugely talented biostatistician who made remarkable contributions to melanoma research.
From Dr. Michael Atkins, Deputy Director of the Georgetown University Cancer Center:
He was such a force for good. His work has had tremendous impact on our understanding of melanoma prognosis. He surely will be missed, both professionally and personally. Seng-jaw taught all of us how to apply statistics to biologic problems. He was the first person to apply Kaplan-Meier survival plots to an infectious diseases problem. Indeed, he paved the way for the success of my career and the careers of many of my colleagues. He was a teacher for all of us. For over thirty years, he helped guide the NIH Antiviral Study Group. With his adroitness at managing and interpreting our data bases, we changed the standard of care for at least six diseases, leading to new drug licensures. 
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In memoriam: Dr. S.-J. Soong (1943 Soong ( -2012 Yes, Seng-jaw Soong left a legacy as a clinical biostatistician and in his innovative use of mathematical modeling that developed predictive tools and outcomes studies used worldwide. He had the intellectual skills to understand the biology and natural history of the diseases he was analyzing. His prowess as a clinical statistician has benefited many patients, and his research has contributed to our fund of knowledge that we use every day around the world.
